A prospective open‐label trial of a CBD/THC cannabis oil in dravet syndrome

INTRODUCTION: Both Δ(9) Tetrahydrocannabidiol (THC) and cannabidiol (CBD) components of cannabis, have been shown to have anticonvulsant effects. Cannabis oils are used to treat seizures in drug‐resistant epilepsy (DRE). Recent trials provide data on dosing, side effects, and efficacy of CBD, yet th...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ann Clin Transl Neurol
Main Authors: McCoy, Bláthnaid, Wang, Laura, Zak, Maria, Al‐Mehmadi, Sameer, Kabir, Nadia, Alhadid, Kenda, McDonald, Kyla, Zhang, Grace, Sharma, Rohit, Whitney, Robyn, Sinopoli, Katia, Snead, O. Carter
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2018
Assuntos:
Research Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6144444/
https://ncbi.nlm.nih.gov/pubmed/30250864
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/acn3.621
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados